ClinicalTrials.gov
public full text
Public Domain
Tongxinluo Capsule in Ischemic Stroke Patients（TISS)
The purpose of this study is to assess the effects in improving life self-care ability of stroke patients after taking Tongxinluo Capsule(within 72 hours after onset) versus Placebos for 90 days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Elucidating the mechanism of Buyang Huanwu Decoction in the treatment of ischemic stroke: A network pharmacology and molecular docking study.#388953
- Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke#1103097
- Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke#994922
- REal-World Analyses of Stroke - Thrombus Occlusion REtrieval#969878
- Implementation of Clinical Pathway to Improve Quality of Healthcare in Stroke Inpatients#1096737
Record · ID 1102271
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive